Home

Galectin Therapeutics, Inc. (GALT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Galectin Therapeutics, Inc. (GALT)

Go deeper and ask any question about GALT

Company Performance

Current Price

as of Sep 13, 2024

$2.87

P/E Ratio

N/A

Market Cap

$178.74M

Description

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Metrics

Overview

  • HQNorcross, GA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerGALT
  • Price$2.87+5.90%

Trading Information

  • Market Cap$178.74M
  • Float69.48%
  • Average Daily Volume (1m)121,177
  • Average Daily Volume (3m)171,797
  • EPS-$0.78

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$12.37M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$11.28M
  • EV$210.74M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
Documents